Dr. Yurth's peptide mixing warning, fact-checked

What did @dryurth actually say?

The creator's core argument is simple: don't mix peptides in one syringe. They claim peptides are "really sensitive to pH changes" and that combining them can cause bond degradation, turning peptides into free amino acids that no longer function as intended. They carve out two exceptions: CJC-1295 with ipamorelin, which they say most practitioners mix without issue, and BPC-157 with thymosin beta-4, which they say should stay in separate syringes but can be injected back-to-back.

The framing is pointed. They call out "doctors selling syringes full of peptides mixed together" as a specific practice to avoid, which is a real criticism worth examining. The practical advice lands somewhere between cautious and reasonable, even if the mechanistic explanation is a bit loose.

Does the science back this up?

Partially, yes. Peptide stability is a real and well-documented concern in pharmaceutical formulation science. pH, temperature, ionic strength, and co-solute interactions all affect peptide integrity. The claim that peptides can degrade into free amino acids when mixed is not wrong in principle, but it overstates what typically happens during short-term co-formulation at room temperature.

Degradation from peptide-peptide interactions in solution is documented in formulation literature, though it usually refers to aggregation, adsorption, or hydrolysis rather than rapid bond cleavage into amino acids. A 2012 review by Manning et al. in Pharmaceutical Research covers peptide and protein stability in solution extensively, noting that hydrolysis and aggregation are the primary degradation pathways, not spontaneous peptide bond breakage from pH alone. The claim is directionally correct but mechanistically imprecise. Real-world compounding stability data for specific peptide combinations like BPC-157 and TB-500 is essentially nonexistent in peer-reviewed literature, which is itself a problem the creator doesn't fully acknowledge.

What did they get wrong (or right)?

They got the general principle right: co-formulation of peptides introduces real stability risks that most online peptide communities ignore entirely. That deserves credit.

Where they slip up is in the mechanism. Saying peptides "break down into separate amino acids" from pH sensitivity during co-injection implies a fast, complete hydrolysis that doesn't match how peptide degradation actually works at physiological or near-physiological pH. Peptide bond hydrolysis under mild acidic or neutral conditions is slow, measured in hours to days, not the seconds of a mixed syringe draw. The bigger legitimate concern is aggregation, where peptides clump together and lose bioavailability, or adsorption to syringe materials.

The CJC-1295 and ipamorelin exception is widely cited in clinical peptide communities and has some practical basis, since both are relatively stable in reconstituted form, but there is no published controlled study confirming their co-formulation is bioequivalent to separate injections. The creator presents this as an established exception when it is really an unchallenged convention.

What should you actually know?

Peptide stability in solution depends on multiple interacting variables: pH, temperature, excipients, light exposure, and the specific amino acid sequences involved. Mixing two peptides doesn't automatically destroy them, but it introduces unknowns that compounding pharmacies account for and that improvised home mixing does not.

The creator's practical recommendation, separate syringes injected close together, is the conservative and defensible approach. It avoids the stability question entirely by keeping formulations isolated. If you're working with a prescribing clinician on peptide therapy, ask specifically whether your pharmacy has stability data for any combined formulation. If they don't, separate syringes are the rational default.

One thing the video skips: reconstituted peptides are typically stored in bacteriostatic water, and that solvent's antimicrobial properties don't extend to protecting peptide structure from degradation. Temperature and light still matter. Mixing peptides in one vial and storing them together compounds the uncertainty. The science here isn't settled enough to be casual about it.